It is a healthcare private not for profit company based in Mumbai, Maharashtra, India, established in 2008.
2008 | Mumbai, Maharashtra, India | ActiveInter System Biomedica Ethics Committee, a active private not for profit company, was established on 24 April 2008 in Mumbai, Maharashtra, India. Engaging in diagnostic & path labs within the healthcare sector, it holds CIN: U85195MH2008NPL181521. Registered under ROC Roc Mumbai. it is unlisted.
It upholds a compliant status. Its leadership includes Vanlila Nagindas Mehta (Director), Deepak Tryambaklal Dave (Director), Jayashree Vinay Joshi (Director). Past directors included Arun Pranjivandas Sangani, Deepak Tryambaklal Dave, Balwant Digamber Samant. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Regus, Near Jw Mariott, Juhu Tara Road, Mumbai, Maharashtra, 400057.
U85195MH2008NPL181521
181521
24 April 2008
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Inter System Biomedica Ethics Committee — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vanlila Nagindas Mehta | Director | 24 Apr 2008 | Current |
| Deepak Tryambaklal Dave | Director | 15 Jun 2009 | Current |
| Jayashree Vinay Joshi | Director | 15 Jun 2009 | Current |
| Meena Laxmishankar Dave | Director | 08 May 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 17 Sep 2009 | Past |
| Pramod Abcsdd | Additional Director | 11 Jul 2009 | Past |
| Pramod Abcsdd | Director | 13 Jun 2019 | Past |
| Pramod Abcsdd | Additional Director | 11 Jul 2009 | Past |
| Pramod Abcsdd | Additional Director | 11 Jul 2009 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Inter System Biomedica Ethics Committee, for the financial year ended 2020, experienced modest growth in revenue, with a 5.37% increase. The company also saw a substantial fall in profitability, with a 274.63% decrease in profit. The company's net worth observed a substantial decline by a decrease of 38.6%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Inter System Biomedica Ethics Committee's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Inter System Biomedica Ethics Committee, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Inter System Biomedica Ethics Committee, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inter System Biomedica Ethics Committee's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Inter System Biomedica Ethics Committee last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Inter System Biomedica Ethics Committee has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
Progress on Meena Laxmishankar Dave was appointed as a Director was appointed as a Director on 08 May 2023 & has been associated with this company since 2 years 7 months . was documented.
Deepak Tryambaklal Dave was appointed as a Director was appointed as a Director on 15 Jun 2009 & has been associated with this company since 16 years 6 months . was recorded as a recent event.
The activity Jayashree Vinay Joshi was appointed as a Director was appointed as a Director on 15 Jun 2009 & has been associated with this company since 16 years 6 months . was completed.
Vanlila Nagindas Mehta was appointed as a Director was appointed as a Director on 24 Apr 2008 & has been associated with this company since 17 years 7 months . was recorded as a recent event.
The CIN of Inter System Biomedica Ethics Committee is U85195MH2008NPL181521.
Inter System Biomedica Ethics Committee is headquartered at Regus, Near Jw Mariott, Juhu Tara Road, Mumbai, Maharashtra, 400057.
Inter System Biomedica Ethics Committee was incorporated on 24 April 2008.
The current directors of Inter System Biomedica Ethics Committee are
The primary industry of Inter System Biomedica Ethics Committee is Healthcare.
Inter System Biomedica Ethics Committee is unlisted.
The compliance status of Inter System Biomedica Ethics Committee is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX